248 related articles for article (PubMed ID: 19118507)
1. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice.
Zhou K; Zhang H; Jin O; Feng X; Yao G; Hou Y; Sun L
Cell Mol Immunol; 2008 Dec; 5(6):417-24. PubMed ID: 19118507
[TBL] [Abstract][Full Text] [Related]
2. Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation.
Ma X; Che N; Gu Z; Huang J; Wang D; Liang J; Hou Y; Gilkeson G; Lu L; Sun L
Cell Transplant; 2013; 22(12):2279-90. PubMed ID: 23127285
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation: a new strategy for intractable diseases.
Ikehara S
Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice.
Gu Z; Akiyama K; Ma X; Zhang H; Feng X; Yao G; Hou Y; Lu L; Gilkeson GS; Silver RM; Zeng X; Shi S; Sun L
Lupus; 2010 Nov; 19(13):1502-14. PubMed ID: 20647254
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of adipose tissue-derived stem cells ameliorates autoimmune pathogenesis in MRL/lpr mice : Modulation of the balance between Th17 and Treg.
Zhang W; Feng YL; Pang CY; Lu FA; Wang YF
Z Rheumatol; 2019 Feb; 78(1):82-88. PubMed ID: 29737401
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.
Ma L; Aijima R; Hoshino Y; Yamaza H; Tomoda E; Tanaka Y; Sonoda S; Song G; Zhao W; Nonaka K; Shi S; Yamaza T
Stem Cell Res Ther; 2015 May; 6(1):104. PubMed ID: 26012584
[TBL] [Abstract][Full Text] [Related]
8. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation.
Ikehara S; Yasumizu R; Inaba M; Izui S; Hayakawa K; Sekita K; Toki J; Sugiura K; Iwai H; Nakamura T
Proc Natl Acad Sci U S A; 1989 May; 86(9):3306-10. PubMed ID: 2654943
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).
Karussis DM; Vourka-Karussis U; Lehmann D; Abramsky O; Ben-Nun A; Slavin S
Clin Exp Immunol; 1995 Apr; 100(1):111-7. PubMed ID: 7697909
[TBL] [Abstract][Full Text] [Related]
10. [Combined mesenchymal stem cells and allogenic bone marrow transplantation in treatment of MRL/lpr mice].
Zhang GF; Zhang X; Dong GF
Zhonghua Nei Ke Za Zhi; 2008 Sep; 47(9):754-7. PubMed ID: 19080203
[TBL] [Abstract][Full Text] [Related]
11. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
[TBL] [Abstract][Full Text] [Related]
12. hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages.
Guo F; Pan Q; Chen T; Liao S; Li S; Li A; Chen S; Chen J; Xiao Z; Su H; Yang L; Yang C; Liu HF; Pan Q
Stem Cell Res Ther; 2023 Aug; 14(1):211. PubMed ID: 37605271
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
Rohraff DM; He Y; Farkash EA; Schonfeld M; Tsou PS; Sawalha AH
Arthritis Rheumatol; 2019 Oct; 71(10):1681-1690. PubMed ID: 31106974
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice.
Gu F; Molano I; Ruiz P; Sun L; Gilkeson GS
Clin Immunol; 2012 Nov; 145(2):142-52. PubMed ID: 23041504
[TBL] [Abstract][Full Text] [Related]
15. Human embryonic mesenchymal stem cells alleviate pathologic changes of MRL/Lpr mice by regulating Th7 cell differentiation.
Yuan L; Xiao ZT; Huang XZ; Wu MJ; Shi H; Liu AF
Ren Fail; 2016 Oct; 38(9):1432-1440. PubMed ID: 27416851
[TBL] [Abstract][Full Text] [Related]
16. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
17. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
Hosaka N; Ryu T; Miyake T; Cui W; Nishida T; Takaki T; Inaba M; Ikehara S
Clin Exp Immunol; 2007 Mar; 147(3):555-63. PubMed ID: 17302907
[TBL] [Abstract][Full Text] [Related]
18. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
[TBL] [Abstract][Full Text] [Related]
19. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation.
Kushida T; Inaba M; Takeuchi K; Sugiura K; Ogawa R; Ikehara S
Blood; 2000 Mar; 95(5):1862-8. PubMed ID: 10688849
[TBL] [Abstract][Full Text] [Related]
20. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R
Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]